Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 GBX | +11.24% | +6.79% | -36.43% |
2023 | EARNINGS: Wynnstay "optimistic" despite climate, dotdigital ups profit | AN |
2023 | Earnings Flash (INHC.L) INDUCTION HEALTHCARE GROUP Posts Fiscal H1 Loss GBP-0.03 | MT |
Valuation
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Capitalization 1 | 26.96 | 45.2 | 37.28 | 19.79 | 11.09 |
Enterprise Value (EV) 1 | 26.96 | 42.73 | 29.78 | 15.5 | 7.885 |
P/E ratio | -7 x | - | -4.05 x | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | 29.9 x | 3.08 x | 1.54 x | 0.79 x |
EV / Revenue | - | 28.2 x | 2.46 x | 1.2 x | 0.56 x |
EV / EBITDA | - | -8.05 x | -7.07 x | -4.31 x | 27 x |
EV / FCF | - | -7.53 x | -5.51 x | -4.27 x | -4.45 x |
FCF Yield | - | -13.3% | -18.2% | -23.4% | -22.4% |
Price to Book | - | 2.59 x | - | 0.82 x | 0.46 x |
Nbr of stocks (in thousands) | 29,626 | 42,051 | 92,051 | 92,051 | 92,380 |
Reference price 2 | 0.9100 | 1.075 | 0.4050 | 0.2150 | 0.1200 |
Announcement Date | 06/08/20 | 23/09/21 | 28/11/22 | 31/07/23 | - |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales 1 | - | 1.513 | 12.12 | 12.88 | 14.08 |
EBITDA 1 | - | -5.311 | -4.213 | -3.6 | 0.2923 |
EBIT 1 | - | -6.658 | -8.026 | -8.5 | -1.758 |
Operating Margin | - | -440.05% | -66.24% | -65.97% | -12.48% |
Earnings before Tax (EBT) | - | - | -9.574 | - | - |
Net income | -3.527 | - | -8.434 | - | - |
Net margin | - | - | -69.6% | - | - |
EPS | -0.1300 | - | -0.1000 | - | - |
Free Cash Flow 1 | - | -5.677 | -5.407 | -3.635 | -1.77 |
FCF margin | - | -375.21% | -44.62% | -28.21% | -12.57% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 06/08/20 | 23/09/21 | 28/11/22 | 31/07/23 | - |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | - | 2.47 | 7.5 | 4.29 | 3.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | -5.68 | -5.41 | -3.64 | -1.77 |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets | - | - | - | - | - |
Book Value Per Share 2 | - | 0.4100 | - | 0.2600 | 0.2600 |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | 3.35 | - | - |
Capex / Sales | - | - | 27.61% | - | - |
Announcement Date | 06/08/20 | 23/09/21 | 28/11/22 | 31/07/23 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.43% | 13.81M | |
-19.95% | 214B | |
-3.37% | 56.39B | |
-10.49% | 46.62B | |
+8.30% | 43.93B | |
-6.51% | 34.19B | |
-7.95% | 29.14B | |
+85.24% | 24.32B | |
+3.45% | 21.64B | |
+3.86% | 13.77B |
- Stock Market
- Equities
- INHC Stock
- Financials Induction Healthcare Group PLC